According to the report, Steven Beumel injected himself with Fentanyl shots intended for patients and then refilling the same syringes with saline solution. The product tampering took place from 2006 through 2008 at the Mayo Clinic’s interventional radiology unit. As a result, five patients contracted hepatitis C, with one case resulting in death.
The Mayo Clinic, as well as state and federal officials, partnered together for three years to determine how the hepatitis C outbreak occurred. Eventually, the infections were linked back to Mr. Beumel, who was fired by Mayo and arrested in May 2011.
Last Friday, Mr. Beumel pled guilty to “tampering with a consumer product resulting in death, four counts of tampering with a consumer product resulting in serious bodily injury and five counts of stealing Fentanyl by deception” in federal court, according to the report. Mr. Beumel alleged he did not know he had hepatitis C, but the judge ruled he must have known the risks his actions posed to patients.
Related Articles on Infection Control:
Alcohol-Impregnated Port Protectors, Needleless Neutral Pressure Connectors Reduce Risk of CLABSI
New HHS Efficiency Rules Include Elimination of “Outdated” Infection Control Regulations
Many Massachusetts Hospital Workers Still Lagging on Vaccinations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
